360 related articles for article (PubMed ID: 10223318)
1. Potency of an experimental DNA vaccine against Aujeszky's disease in pigs.
Gerdts V; Jöns A; Mettenleiter TC
Vet Microbiol; 1999 Mar; 66(1):1-13. PubMed ID: 10223318
[TBL] [Abstract][Full Text] [Related]
2. Protection of pigs against Aujeszky's disease by DNA vaccination.
Gerdts V; Jöns A; Makoschey B; Visser N; Mettenleiter TC
J Gen Virol; 1997 Sep; 78 ( Pt 9)():2139-46. PubMed ID: 9291999
[TBL] [Abstract][Full Text] [Related]
3. A DNA vaccine coding for glycoprotein B of pseudorabies virus induces cell-mediated immunity in pigs and reduces virus excretion early after infection.
van Rooij EM; Haagmans BL; Glansbeek HL; de Visser YE; de Bruin MG; Boersma W; Bianchi AT
Vet Immunol Immunopathol; 2000 Apr; 74(1-2):121-36. PubMed ID: 10760394
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a quadruple glycoprotein-deleted pseudorabies virus mutant for use as a biologically safe live virus vaccine.
Mettenleiter TC; Klupp BG; Weiland F; Visser N
J Gen Virol; 1994 Jul; 75 ( Pt 7)():1723-33. PubMed ID: 8021601
[TBL] [Abstract][Full Text] [Related]
5. An inactivated gE-deleted pseudorabies vaccine provides complete clinical protection and reduces virus shedding against challenge by a Chinese pseudorabies variant.
Wang J; Guo R; Qiao Y; Xu M; Wang Z; Liu Y; Gu Y; Liu C; Hou J
BMC Vet Res; 2016 Dec; 12(1):277. PubMed ID: 27923365
[TBL] [Abstract][Full Text] [Related]
6. Effect of vaccination route and composition of DNA vaccine on the induction of protective immunity against pseudorabies infection in pigs.
van Rooij EM; Haagmans BL; de Visser YE; de Bruin MG; Boersma W; Bianchi AT
Vet Immunol Immunopathol; 1998 Nov; 66(2):113-26. PubMed ID: 9860185
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of antibodies of field pseudorabies virus in pigs of herd vaccinated with live vaccine.
Asai T; Tajima M; Watanabe H; Shibata I
J Vet Med Sci; 1998 Mar; 60(3):399-400. PubMed ID: 9560796
[TBL] [Abstract][Full Text] [Related]
8. Effective protection of pigs against lethal Pseudorabies virus infection after a single injection of low-dose Sindbis-derived plasmids encoding PrV gB, gC and gD glycoproteins.
Dory D; Torché AM; Béven V; Blanchard P; Loizel C; Cariolet R; Jestin A
Vaccine; 2005 May; 23(26):3483-91. PubMed ID: 15837372
[TBL] [Abstract][Full Text] [Related]
9. Vaccine genotype and route of administration affect pseudorabies field virus latency load after challenge.
Vilnis A; Sussman MD; Thacker BJ; Senn M; Maes RK
Vet Microbiol; 1998 May; 62(2):81-96. PubMed ID: 9695282
[TBL] [Abstract][Full Text] [Related]
10. Survival and immunization of raccoons after exposure to pseudorabies (Aujeszky's disease) virus gene-deleted vaccines.
Weigel RM; Hahn EC; Scherba G
Vet Microbiol; 2003 Mar; 92(1-2):19-24. PubMed ID: 12488067
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with recombinant vaccinia virus vaccines expressing glycoprotein genes of pseudorabies virus in the presence of maternal immunity.
Brockmeier SL; Lager KM; Mengeling WL
Vet Microbiol; 1997 Nov; 58(2-4):93-103. PubMed ID: 9453121
[TBL] [Abstract][Full Text] [Related]
12. A live gI/gE-deleted pseudorabies virus (PRV) protects weaned piglets against lethal variant PRV challenge.
Yin Y; Xu Z; Liu X; Li P; Yang F; Zhao J; Fan Y; Sun X; Zhu L
Virus Genes; 2017 Aug; 53(4):565-572. PubMed ID: 28417300
[TBL] [Abstract][Full Text] [Related]
13. A novel inactivated gE/gI deleted pseudorabies virus (PRV) vaccine completely protects pigs from an emerged variant PRV challenge.
Gu Z; Dong J; Wang J; Hou C; Sun H; Yang W; Bai J; Jiang P
Virus Res; 2015 Jan; 195():57-63. PubMed ID: 25240533
[TBL] [Abstract][Full Text] [Related]
14. Vaccination of pigs against pseudorabies virus with plasmid DNA encoding glycoprotein D.
Haagmans BL; van Rooij EM; Dubelaar M; Kimman TG; Horzinek MC; Schijns VE; Bianchi AT
Vaccine; 1999 Mar; 17(9-10):1264-71. PubMed ID: 10195639
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of specific humoral immune response in pigs vaccinated intradermally with deleted Aujeszky's disease vaccine and challenged with virulent strain of Herpesvirus suis type 1.
Mikulska-Skupień E; Szweda W; Procajło Z
Pol J Vet Sci; 2005; 8(1):11-6. PubMed ID: 15794468
[TBL] [Abstract][Full Text] [Related]
16. Development of active immunity in newborn pigs with colostral antibodies by vaccination with gIII-deleted PRV.
Kit S; Kit M; McConnell S; Lawhorn B
Acta Vet Hung; 1994; 42(2-3):319-30. PubMed ID: 7810426
[TBL] [Abstract][Full Text] [Related]
17. Growth properties and vaccine efficacy of recombinant pseudorabies virus defective in glycoprotein E and thymidine kinase genes.
Wu CY; Liao CM; Chi JN; Chien MS; Huang C
J Biotechnol; 2016 Jul; 229():58-64. PubMed ID: 27164258
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a recombinant vaccinia virus containing pseudorabies (PR) virus glycoprotein genes gp50, gII, and gIII as a PR vaccine for pigs.
Mengeling WL; Brockmeier SL; Lager KM
Arch Virol; 1994; 134(3-4):259-69. PubMed ID: 8129615
[TBL] [Abstract][Full Text] [Related]
19. A gD&gC-substituted pseudorabies virus vaccine strain provides complete clinical protection and is helpful to prevent virus shedding against challenge by a Chinese pseudorabies variant.
Zhang C; Liu Y; Chen S; Qiao Y; Guo M; Zheng Y; Xu M; Wang Z; Hou J; Wang J
BMC Vet Res; 2019 Jan; 15(1):2. PubMed ID: 30606159
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of an attenuated Chinese pseudorabies variant by dual deletion of TK&gE genes.
Wang J; Song Z; Ge A; Guo R; Qiao Y; Xu M; Wang Z; Liu Y; Zheng Y; Fan H; Hou J
BMC Vet Res; 2018 Sep; 14(1):287. PubMed ID: 30241529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
